Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Obesity, Morbid 1Obesity 1Fistula 1Esophageal Neoplasms 1Anastomotic Leak 1

Interventions

Bevacizumab 5Capecitabine 3toripalimab 2olaparib 2durvalumab 2darolutamide 2atezolizumab 2apatinib 2anlotinib 2Standard of Care 2Radiotherapy 2Radiosurgery 2Oxaliplatin 2Leucovorin 2Laparoscopy 2Immunotherapy 2Fluorouracil 2Everolimus 2Drug Therapy 2Blood Specimen Collection 2130-nm albumin-bound paclitaxel 2trametinib 1spartalizumab 1pyrotinib 1pomalidomide 1palbociclib 1nilotinib 1ledipasvir, sofosbuvir drug combination 1ledipasvir 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Stents × 90 days × Clear all
NCT06862479 2026-05-06

ES-LCCE-UDFM

Unidade Local de Saúde Santa Maria

Enrolling by invitation
180 enrolled
GastrointestinalOther

Esophageal Neoplasms, Fistula, Obesity, Obesity, Morbid, Stomach Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡